Doximity (DOCS)
(Delayed Data from NYSE)
$24.27 USD
+0.45 (1.89%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $24.25 -0.02 (-0.08%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
DOCS 24.27 +0.45(1.89%)
Will DOCS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DOCS
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?
Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?
SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?
Other News for DOCS
What's Driving R1 RCM Inc's Surprising 15% Stock Rally?
IN THE KNOW: Deutsche highlights value in Frasers and Mothercare
Doximity’s Strong Market Position Amidst Economic Headwinds: A Balanced Hold Recommendation
LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD
Doximity: Significant Upside Remains, But Not Until The Growth Story Returns